Article info

Download PDFPDF

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma

Authors

  1. a dm3{at}medicine.wisc.edu
  2. b nhbander{at}med.cornell.edu
  3. c beert{at}ohsu.edu
  4. d cdrake{at}jhmi.edu
  5. e lfong{at}medicine.ucsf.edu
  6. f sharrelson{at}atlanticurologyclinics.com
  7. g kantoff{at}mskcc.org
  8. h madanr{at}mail.nih.gov
  9. i william.oh{at}mssm.edu
  10. j dpeace{at}uic.edu
  11. k daniel.petrylak{at}yale.edu
  12. l pchank{at}comcast.net
  13. m osartor{at}tulane.edu
  14. n nshore{at}gsuro.com
  15. o slovins{at}mskcc.org
  16. p steinmn{at}cinj.rutgers.edu
  17. q jvieweg{at}nova.edu
  18. r gulleyj{at}mail.nih.gov
View Full Text

Citation

McNeel DG, Bander NH, Beer TM, et al
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma

Publication history

  • Received August 16, 2016
  • Accepted November 23, 2016
  • First published December 20, 2016.
Online issue publication 
December 20, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.